Astrocyte-targeted GPX4 overexpression or System Xc⁻ enhancement to prevent iron-dependent lipid peroxidation in glia, reducing non-cell-autonomous motor neuron toxicity. Very low priority due to pathway confusion, poor drug properties, and consistent antioxidant failures in ALS.
AAV9-mediated overexpression of LAMP2A enhances chaperone-mediated autophagy to selectively degrade pathological alpha-synuclein species, preventing Lewy body formation and blocking cell-to-cell propagation. Strongest mechanistic foundation with validated AAV platform and clear patient stratification via seed amplification assays.
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
AutophagyUnspecified Mechanismneurodegeneration
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
1/11
dimensions won
Glial-Specific Ferroptosis Resistance vi
11/11
dimensions won
LAMP2A-Mediated Autophagy Enhancement Bl
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.45
0.80
Evidence
0.45
0.75
Novelty
0.65
0.70
Feasibility
0.35
0.75
Impact
0.50
0.80
Druggability
0.40
0.70
Safety
0.55
0.65
Competition
0.50
0.75
Data
0.60
0.80
Reproducible
0.55
0.75
KG Connect
0.50
0.50
Score Breakdown
Dimension
Glial-Specific Ferroptosis Res
LAMP2A-Mediated Autophagy Enha
Mechanistic
0.450
0.800
Evidence
0.450
0.750
Novelty
0.650
0.700
Feasibility
0.350
0.750
Impact
0.500
0.800
Druggability
0.400
0.700
Safety
0.550
0.650
Competition
0.500
0.750
Data
0.600
0.800
Reproducible
0.550
0.750
KG Connect
0.500
0.500
Evidence
Glial-Specific Ferroptosis Resistance via GPX4 Enhancement P